Holmén, Elin
Warnqvist, Anna
Kåberg, Martin
Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2021-01715, 2021-01715, 2021-01715)
Region Stockholm (20200431, 20200431, 20200431)
Karolinska Institute
Article History
Received: 22 January 2023
Accepted: 4 April 2023
First Online: 22 April 2023
Declarations
:
: The study was performed in accordance with the Helsinki declaration and was approved by The Regional Ethical Review Board in Stockholm (Dnr: 2013/495–31/3, 2015/1374–32 and 2020–03325). Ethical approval included usage of research data from the quality register InfCare NSP. No additional informed consent was needed from participants.
: Not applicable.
: MK has received honoraria for lectures/consultancy from AbbVie, Gilead, MSD, Mundipharma, DnE Pharma and Nordic Drugs and has received research grants from Gilead and Nordic Drugs.